Immunocore Holdings Plc
Overview
Immunocore Holdings Plc is a pioneering biotechnology company focused on developing T cell receptor-based therapeutics to treat cancer, infectious diseases, and autoimmune conditions. The company's innovative immune-oncology approach uniquely harnesses and enhances the body's intrinsic immune capabilities to selectively target and combat specific diseases.
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- recall — Class II2025-09-10
Subpotent Drug
Verified Supplier Partner
Is this Immunocore Holdings Plc? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.